Business Context and Reporting Period
Company: The Hain Celestial Group, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2002
Business Overview: A leading manufacturer and marketer of natural, specialty, organic, and snack food products. The company operates in a single segment, selling brands such as Celestial Seasonings, Earth's Best, and Terra Chips. Approximately 54% of revenues are derived from in-house manufacturing, with the remainder produced by co-packers.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2002 | Three Months Ended Sep 30, 2001 |
|---|---|---|
| Net Sales | $96.4 million | $89.7 million |
| Gross Profit | $29.3 million (30.3% margin) | $26.7 million (29.7% margin) |
| Operating Income | $7.7 million (8.0% margin) | $9.1 million (10.2% margin) |
| Net Income | $4.7 million | $5.4 million |
| Earnings Per Share (Diluted) | $0.14 | $0.16 |
| Cash and Equivalents | $3.9 million | $14.0 million |
| Total Debt (Current + Long-term) | $13.7 million | Not explicitly stated for 2001 total |
| Working Capital | $72.6 million | Not explicitly stated for 2001 |
| Current Ratio | 2.4 to 1 | Not explicitly stated for 2001 |
Cash Flow Summary: Net cash used in operating activities was $1.2 million. Net cash used in investing activities was $2.0 million (primarily capital expenditures). Net cash used in financing activities was $0.3 million (primarily treasury stock purchases).
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7.5% year-over-year. On a comparable basis (excluding discontinued lines), sales increased approximately 10%, driven by the acquisition of Lima/Biomarche (contributing ~6% of the increase) and internal growth from Yves, Earth's Best, and Health Valley brands.
- Profitability Decline: Operating income decreased 15.7% to $7.7 million. This was primarily due to a $4.0 million increase in Selling, General, and Administrative (SG&A) expenses, which rose to 22.4% of sales from 19.5% in the prior year. The increase in SG&A was attributed to the Lima acquisition and higher marketing costs.
- Restructuring Charges: The company recorded $21.3 million in pre-tax charges in the prior fiscal year's fourth quarter related to the sale of the Health Valley facility and discontinuation of the supplements business and Weight Watchers licenses. While these charges were recorded previously, $6.1 million in accrued restructuring costs remained on the balance sheet as of September 30, 2002.
- Liquidity: Cash and cash equivalents decreased significantly from $7.5 million at June 30, 2002, to $3.9 million at September 30, 2002, due to operating cash outflows and treasury stock repurchases.
Guidance, Outlook, and Risks
- Guidance: Management reaffirmed quarterly and full fiscal year 2003 net sales and earnings guidance in a presentation on September 4, 2002. Specific numerical targets for the full year were not detailed in this text.
- Capital Resources: The company maintains a $240 million Credit Facility ($145 million revolving, $95 million 364-day). As of September 30, 2002, approximately $6.2 million was borrowed under this facility. Management believes current cash, projected operating flows, and credit availability are sufficient to fund operations, capital expenditures ($8.0 million anticipated for remainder of fiscal 2003), and restructuring costs.
- Seasonality: The tea business is seasonal, with higher demand in cooler months. Quarterly results may fluctuate due to trade promotions, weather, and commodity costs.
- Risks: Key risks include the ability to integrate acquisitions, competition, availability of key personnel, and compliance with government regulations. The company notes that two customers represent approximately 30% of trade receivables, though no current credit exposure is identified.
Investor Verification Checklist
- Restructuring Accruals: Verify the $6.1 million accrued restructuring liability and the anticipated additional $2 million in charges for fiscal 2003 related to severance and trade items.
- Health Valley Facility Sale: Confirm the final terms and cash proceeds from the sale of the Health Valley manufacturing facility consummated on September 30, 2002.
- Acquisition Integration: Assess the financial performance and integration progress of the Lima/Biomarche acquisition, which contributed significantly to recent sales growth but impacted gross margins.
- Debt Covenants: Review compliance with affirmative and negative covenants under the $240 million Credit Facility.
- Discontinued Operations: Monitor the impact of the discontinued supplements business and Weight Watchers license on future revenue streams and inventory write-downs.